Sign in
4

Changes in Ownership

Ensysce Biosciences, Inc. Filed Acc 0001493152-22-017877

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rauch Lee M. Director 2022-06-23 Grant or award · Stock Option +15,000 35,000 D
Loading xslF345X03/ownership.xml…